B

Bellevue Group AG Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Bellevue Group AG with $4.8B in long positions as of Q3 2025, 88% allocated to Healthcare, and 50% concentrated in top 10 positions.

Portfolio Value
$4.8B
Top 10 Concentration
50%
Top Sector
Healthcare (88%)
US Exposure
97%
Market Cap Focus
Large Cap
Countries
5

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 88.30%HealthcareTechnology: 0.10%ETF: 0.10%
Healthcare
88.30%
Technology
0.10%
ETF
0.10%

Industry Breakdown

20 industries across all sectors

Biotechnology: 42.96%BiotechnologyMedical - Devices: 19.95%Medical - DevicesMedical - Instruments & Supplies: 6.44%Drug Manufacturers - Specialty & Generic: 5.16%Medical - Diagnostics & Research: 4.18%Medical - Healthcare Plans: 3.73%14 more: 6.20%
Biotechnology
Healthcare
42.96%
Medical - Devices
Healthcare
19.95%
Medical - Instruments & Supplies
Healthcare
6.44%
Drug Manufacturers - Specialty & Generic
Healthcare
5.16%
Medical - Diagnostics & Research
Healthcare
4.18%
Medical - Healthcare Plans
Healthcare
3.73%
Drug Manufacturers - General
Healthcare
2.08%
Medical - Healthcare Information Services
Healthcare
2.05%
Medical - Care Facilities
Healthcare
1.10%
Medical - Distribution
Healthcare
0.70%
Information Technology Services
Technology
0.10%
ETF
ETF
0.084%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 7.20%Large Cap ($10B - $200B): 54.35%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 20.09%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 6.72%Micro Cap ($50M - $300M): 0.35%Nano Cap (< $50M): 0.04%N/A (ETF or Unknown): 11.26%N/A (ETF or Unknown)
Mega Cap (> $200B)
7.20%
Large Cap ($10B - $200B)
54.35%
Mid Cap ($2B - $10B)
20.09%
Small Cap ($300M - $2B)
6.72%
Micro Cap ($50M - $300M)
0.35%
Nano Cap (< $50M)
0.04%
N/A (ETF or Unknown)
11.26%

Portfolio Concentration

Top 10 Holdings %
50.06%
Top 20 Holdings %
71.0%
Top 50 Holdings %
92.88%
Top 100 Holdings %
99.59%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
97.14%
International
2.86%
Countries
5
Largest Int'l Market
Ireland - 2.21%
United States of America
97.14% ($4.7B)
137 holdings
Ireland
2.21% ($106.0M)
4 holdings
Singapore
0.62% ($30.0M)
1 holdings
Netherlands
0.02% ($771.2K)
3 holdings
Switzerland
0.02% ($751.4K)
2 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
33.4 quarters
Avg. Top 20
27 quarters
Avg. All Positions
16.7 quarters
Median Holding Period
11 quarters
Persistence Rate
76.87%
Persistent Holdings Weight
94.33%
Persistent Positions
113
Longest Held
Ionis Pharmaceuticals, Inc. Common Stock logo
Ionis Pharmaceuticals, Inc. Common StockIONS - 38 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.30%
Avg. Position Weight
0.68%
Largest Position
Ionis Pharmaceuticals, Inc. Common Stock logo
Ionis Pharmaceuticals, Inc. Common StockIONS - 8.51%
Largest Ownership Stake
MacroGenics, Inc. logo
MacroGenics, Inc.MGNX - 15.69%
Avg. Ownership Stake
1.38%
Ownership Stake >5%
3
Ownership Stake >1%
16

Historical (Since Q1 2016)

Avg. New Position
0.37%
Avg. Ownership Stake
1.89%
Largest Position
Ionis Pharmaceuticals, Inc. Common Stock logo
Ionis Pharmaceuticals, Inc. Common StockIONS - 11.72% (Q3 2019)
Largest Ownership Stake
Black Diamond Therapeutics, Inc. Common Stock logo
Black Diamond Therapeutics, Inc. Common StockBDTX - 22.28% (Q2 2023)

Portfolio Turnover

Current Quarter

Turnover Ratio
8.4%
Value Traded
$401.91M
Positions Added
7
Positions Exited
11

Historical (Since Q1 2016)

Avg. Turnover Ratio
10.4%
Avg. Positions Added
14
Avg. Positions Exited
13
Highest Turnover
50.0%
Q1 2016
Lowest Turnover
3.2%
Q3 2022

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.